ScreenerHero

PLRZPolyrizon Ltd. Ordinary Shares

NAS · US · Basic Materials · Biotechnology · polyrizon-biotech.com
10.30USDMkt Cap: 19.28M $P/E: —

Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and …

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap19.28M $
Enterprise Value5.88M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-3.33M $
Revenue/Share—
Last Price10.30 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees2
CountryUS
SectorBasic Materials
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-0.99
EV/Revenue—
P/S—
P/B0.80
EPS (TTM)-4.90
EPS (Forward)—
52W Range
10.2511% of range10.68
52W High10.68 USD
52W Low10.25 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-15.89%
ROA-15.56%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.53M $
CapEx (TTM)7.00K $
FCF Margin—
FCF Yield-13.31%
Net Debt-12.27M $
Net Debt/EBITDA2.08
Balance Sheet
Debt/Equity—
Current Ratio29.03
Quick Ratio27.70
Book Value/Sh13.05 USD
Cash/Share7.566 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:6
Split DateNov 28, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.87M
Float1.36M
Insiders0.83%
Institutions10.64%
Short Interest
Short Ratio1.1d
Short % Float3.08%
Short % Out.3.04%
Shares Short63.32K
Short (prev mo.)40.46K
Technical
SMA 5012.37 (-16.7%)
SMA 20012.07 (-14.7%)
Beta—
S&P 52W Chg21.00%
Avg Vol (30d)20.94K
Avg Vol (10d)67.57K
Technical Indicators
RSI (14)41.6
MACD-0.6362
MACD Signal-0.6487
MACD Hist.+0.0125
BB Upper12.86 USD
BB Middle11.06 USD
BB Lower9.270 USD
BB Width32.43%
ATR (14)1.413 USD
Vol Ratio (20d)0.26x